arrow
R

Ruitao Lin

The University of Texas MD Anderson Cancer Center
H指数:22
被引数:1,914

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment

基于贝叶斯个性化剂量约束的肺癌非小细胞癌患者心脏风险自适应治疗患者选择

2026-09-120
PRE
Surgical Reconstruction Toxicity Following Hypofractionated Adjuvant Radiotherapy for Primary Cutaneous Melanoma

原发性皮肤黑色素瘤术后辅助性低分割放疗后的手术重建毒性

2025-12-090
PRE
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy Prescription

基于个性化放疗方案,利用贝叶斯学习降低局部晚期NSCLC患者的心脏风险

2025-12-070
PRE
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses

前瞻性II期临床试验:分子胶质母细胞瘤(历史分级2级和3级IDH野生型胶质瘤)初步的探索性分析

2025-11-050
OAAI
Radiation doses to cardiac substructures predict elevation in high-sensitivity cardiac troponin T (hs-cTnT) levels in radiotherapy for lung cancer

肺癌放疗中,心脏亚结构受到的辐射剂量可预测高敏感性心肌肌钙蛋白T(hs-cTnT)水平的升高。

2025-10-170
PRE
Response to recent comments on Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy
2025-03-010
PRE
Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy

使用3d打印口腔支架的数字工作流程的开发和临床实施,用于接受放射治疗的头颈癌患者

2024-10-012
OAAI
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results (vol 9, pg 898, 2023)
2024-04-220
OAAI
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma
2024-04-011
PRE